 MARSEILLE, France--BUSINESS WIRE--Regulatory News: Innate Pharma SA Euronext Paris: IPH; Nasdaq: IPHA Innate or the Company today announced that its investor relation team will participate in the following upcoming investor conference: Conference Portzamparc Evenement Corporate Access, Paris in-person event Event Date: June 30, 2022 About Innate Pharma: Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical out 